BioPharma, Inc.

Overview

BioPharma, Inc. is a leading biotech company focused on developing innovative therapies for unmet medical needs. The company is committed to advancing medical research and delivering breakthrough products to improve patient outcomes.

Therapeutic areas

API / Drug Master Files

BioPharma, Inc. holds 10 active (10 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• RM-6250 DRUG-LINKERActive2025-09-19
• SC3417 DRUG-LINKERActive2025-09-17
• SC239 DRUG-LINKERActive2024-08-22
• SP6188 PREFABRICATED LIGHT CHAIN (PFLC)Active2024-08-14
• IVABRADINE HYDROCHLORIDEActive2018-09-21
• XTRACTCF™ REAGENTActive2017-10-02
• TRNA AND AMINOACYL TRNA SYNTHETASE REAGENTSActive2017-10-02
• T7 RNA POLYMERASE REAGENTActive2017-10-02
• PEPTIDE DEFORMYLASE REAGENTActive2017-10-02
• DAPAGLIFLOZINActive2017-09-01

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to BioPharma, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.